New synthetic lethality re-sensitizing platinum-refractory cancer cells to cisplatin in vitro: The rationale to co-use parp and atm inhibitors

Watson P. Folk, Alpana Kumari, Tetsushi Iwasaki, Erica K. Cassimere, Slovénie Pyndiah, Elizabeth Martin, Kelly Homlar, Daitoku Sakamuro

Research output: Contribution to journal › Article › peer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'New synthetic lethality re-sensitizing platinum-refractory cancer cells to cisplatin in vitro: The rationale to co-use parp and atm inhibitors'. Together they form a unique fingerprint.

Physics & Astronomy

Engineering & Materials Science

Medicine & Life Sciences

Chemical Compounds